Background-Environmental and genetic correlates of inflammatory marker variability are incompletely understood. In the family-based Framingham Heart Study, we investigated heritability and candidate gene associations of systemic inflammatory biomarkers. Methods and Results-In offspring participants (nϭ3710), we examined 11 inflammatory biomarkers (CD40 ligand, C-reactive protein, intercellular adhesion molecule-1, interleukin-6, urinary isoprostanes, monocyte chemoattractant protein-1, myeloperoxidase, P-selectin, tumor necrosis factor-␣, tumor necrosis factor receptor II, fibrinogen). Heritability and bivariate genetic and environmental correlations were assessed by Sequential Oligogenic Linkage Analysis routines in 1012 family members. We examined 1943 tagging single-nucleotide polymorphisms in 233 inflammatory pathway genes with Ն5 minor allele carriers using a general genetic linear model. Clinical correlates explained 2.4% (CD40 ligand) to 28.5% (C-reactive protein) of the variability in inflammatory biomarkers. Estimated heritability ranged from 10.9% (isoprostanes) to 44.8% (P-selectin). Most correlations between biomarkers were weak although statistically significant. A total of 45 single-nucleotide polymorphism-biomarker associations met the q-value threshold of 0.25. Novel top single-nucleotide polymorphisms were observed in ICAM1 gene in relation to intercellular adhesion molecule-1 concentrations (rs1799969, Pϭ1.32ϫ10 Ϫ8 ) and MPO in relation to myeloperoxidase (rs28730837, Pϭ1.9ϫ10 Ϫ5 ). Lowest P values for trans-acting single-nucleotide polymorphisms were observed for APCS with monocyte chemoattractant protein-1 concentrations (rs1374486, Pϭ1.01ϫ10 Ϫ7 ) and confirmed for IL6R with interleukin-6 concentrations (rs8192284, Pϭ3.36ϫ10 Ϫ5 ). Novel potential candidates (APCS, MPO) need to be replicated.
biomarker concentrations are heritable phenotypes. 10, 11 For instance, estimated C-reactive protein (CRP) concentration heritability is at least 20%. 12 Several single-nucleotide polymorphisms (SNPs) are associated with adjusted CRP concentrations and the degree of chronic low-grade inflammation. [13] [14] [15] However, the genetic contribution to systemic concentrations of most inflammatory markers remains incompletely understood.
We hypothesized that in a community-based cohort, enrolled irrespective of phenotype, SNPs in inflammatory gene regions are associated with concentrations of proinflammatory biomarkers. The well-characterized Framingham Heart Study (FHS) provides a unique opportunity to examine the association of genetic and environmental factors with inflammatory biomarkers.
Methods

Study Sample
Participants were eligible if they attended the seventh examination cycle (1998 to 2001, nϭ5124) of the FHS Offspring, a white, community-based cohort of European ancestry enrolled in 1971. 16, 17 Reasons for exclusion from analyses were off-site visits (nϭ207), none of the 11 biomarkers available (nϭ10), and missing covariate data (nϭ17). Heritability and correlations were estimated in 1843 phenotyped individuals in 567 families, in addition to 1468 unrelated participants. To be resource effective and to maximize statistical power, we focused on unrelated individuals and hence genotyped 1565 randomly selected individuals on the standard offspring unrelated plate set. This plate set is one of several standard Framingham plate sets that is publicly available to researchers.
According to protocol, all participants underwent routine medical history, physical examination, and laboratory testing at the FHS (see supplement for details). The study was approved by the Boston University Medical Center Institutional Review Board and the participants signed informed consent.
Determination of Inflammatory Biomarkers
Fasting biomarkers, selected to represent various phases and functions in the inflammation process (supplement Table I ) included CD40 ligand, CRP, fibrinogen, intercellular adhesion molecule-1 (ICAM1), interleukin (IL)-6, urinary isoprostanes indexed to urinary creatinine (isoprostanes), monocyte chemoattractant protein-1, myeloperoxidase, P-selectin, tumor necrosis factor receptor II, and tumor necrosis factor-␣. Biomarkers methods have been detailed previously. 18 The mean inflammatory biomarkers' intra-assay coefficients of variation were Ͻ10%.
Genotyping
Genotyping (2942 SNPs in 233 candidate inflammation genes) was conducted by Perlegen Sciences, Inc (Mountain View, Calif) using high-density oligonucleotide, photolithographic microarrays (DNA chips). Common SNPs were chosen from a genome-wide compilation discovered by Perlegen Sciences and supplemented with others from the HapMap project (build 35), if they had Ͼ4% (or unknown) minor allele frequency in the HapMap Utah residents with ancestry from northern and western Europe (CEU) samples or were coding SNPs. To obtain maximum information, a binning procedure was used to identify tagging SNPs with a criterion of r 2 Ͼ0.8 to create bins; 1 or 2 SNPs were selected from each bin depending on bin size. Candidate gene selection details have been reported earlier. 18 Because SNPs with low call rates showed excess departure from Hardy-Weinberg equilibrium, we restricted our analyses to a subset of 1834 SNPs with call rate Ն98% and Hardy-Weinberg equilibrium PϾ0.01. Only SNPs with at least 5 minor allele carriers in the Framingham sample were evaluated for association. An additional 109 SNPs in 9 candidate inflammatory genes previously genotyped by the CardioGenomics project (http://cardiogenomics.med. harvard.edu/genes/gene-list) on the Sequenom MassARRAY platform, with call rate Ն90% and Hardy-Weinberg equilibrium PՆ0.01 were included in the present report, for a total of 1943 SNPs in 233 genes.
Statistical Analysis
Multiple regression analysis was performed on the log-transformed biomarker phenotypes to obtain residuals adjusted for age, sex, cohort (Omni), current smoking, systolic and diastolic blood pressures, hypertension treatment, body mass index, waist circumference, total/high-density lipoprotein cholesterol, triglycerides, lipidlowering medication, glucose, diabetes, aspirin (Ն3 days per week), hormone replacement therapy, and prevalent cardiovascular disease. For genetic analyses, we adjusted for the same covariates across markers for simplification. The residuals of the log-transformed biomarker phenotypes were rescaled to mean 0 and SD 1.
Genetic Analyses
The statistical methods for assessing heritability for biomarkers was described previously. 10 Sequential Oligogenic Linkage Analysis (www.sfbr.org/pages/genetics_projects.php? Pϭ37) was used to estimate residual log-biomarker concentration heritability for age-and sex-adjusted and multivariable-adjusted models and to calculate correlations. The correlation coefficient between any 2 covariateadjusted ln-transformed inflammatory biomarker concentrations was decomposed into genetic and environmental components.
ANOVA was performed to compare means of log-biomarker residuals (model 1: age and sex; model 2: age, sex, and multiple variables) among inflammatory SNP genotypes using a general genetic model (2 degrees of freedom). ANOVA is not robust for SNPs with low minor allele frequency (MAF); we used the nonparametric Kruskal-Wallis test instead for SNPs with fewer than 10 individuals in the lowest frequency genotype category. Within each biomarker phenotype, the q-value method, 19 a variation of the false discovery rate method, to adjust for multiple testing. We used a threshold of qϽ0.25 to identify potentially important findings, meaning that the expected proportion of false-positive tests among the tests we report within each phenotype is 25%.
Secondary Analyses
We assessed potential interactions of 10 SNPs with the smallest P value for each biomarker with sex, age, smoking status, and body mass index using linear regression. The full set of covariates were included in the model, as well as the SNP (coded with 2 degrees of freedom), and a 2-parameter SNP by covariate interaction term.
Replication From the Literature
We searched the PubMed for English language literature that reported SNP-biomarker associations with the inflammatory phenotypes characterized in our sample in studies comprising at least 500 individuals that reached statistical significance level of PՅ0.05 and provided the direction of association. We identified SNPs reported in the publications or allowed for proxies with a linkage disequilibrium r 2 of Ն0.5 in our database and provided the association P value. We omitted CRP and P-selectin associations in cis-acting SELP and CRP genes because we have previously reported on both. 20, 21 In the online supplement, we provide the comprehensive results on SNPcirculating biomarker association studies that were available for the search terms inflammation, inflammatory biomarkers, and SNPs, or genetics (August 2008).
Phenotype residuals were created using SAS version 8.1 (Cary, NC, http://www.sas.com/presscenter/guidelines.html). Genetic analyses were performed with R (www.r-project.org). All authors had full access to the data, take responsibility for its integrity, and have read and agree to the manuscript as written.
External Replication
External replication was attempted in the previously described AtheroGene cohort 22 in up to 1752 patients with documented coronary artery disease and 430 controls free of manifest cardiovascular disease. We confined replication to top findings in the current study to limit the number of tests performed. SNPs were selected if they had not been reported in the literature in comparable studies, were in trans-acting genes, and were in low linkage disequilibrium (r 2 Ͻ0.5) with other top SNPs. Residuals were created using age, sex, case-control status, smoking status, body mass index, total/highdensity lipoprotein cholesterol, triglycerides, serum glucose, diabetes, hypertension, and lipid treatment.
Results
Participant Characteristics
The clinical and laboratory characteristics of the study cohort have been reported before. 20 The heritability and genotype samples' characteristics are outlined in supplement Table II . Briefly, the mean age of the genotyped sample was 62Ϯ9 years, 51% were women, and the cardiovascular disease prevalence was 13%. Clinical variables explained between 2.4% (CD40 ligand) to 28.5% (CRP) of inflammatory biomarker variability (supplement Table III ).
Heritability
All inflammatory traits were heritable (PϽ0.05; Table 1 , second/third column); estimated multivariable-adjusted heritability values ranged from 10.9% (isoprostanes) to 44.8% (P-selectin); age-and sex-adjusted results were generally slightly higher. The Pearson correlation coefficients and portion of correlation due to genetic factors also are displayed. Significant environmental correlations were observed for 24 biomarker combinations. Strongest overall pairwise correlations were observed for CRP with fibrinogen (ϭ0.48), and IL-6 (ϭ0.39). Six genetic correlations were seen with highest correlation coefficients for fibrinogen and CRP (0.14), and for IL-6 and P-selectin (0.12).
Genetic Association
To account for multiple testing, we computed false discovery rates. 23 A total of 45 associations were significant at a cutoff qϽ0.25. Lowest P values for trans-acting (not involving the protein-coding gene) SNPs were observed for APCS (rs1374486, Pϭ1.01ϫ10 Ϫ7 , and rs6695377, 5Ј near gene, Pϭ1.85ϫ10 Ϫ7 ) with monocyte chemoattractant protein-1 concentrations, IL6R (rs8192284, Ala/Asp missense, Pϭ3.36ϫ10 Ϫ5 ) with IL-6 concentrations, and MPO in relation to myeloperoxidase (rs28730837, Val/Ala missense, Pϭ1.9ϫ10 Ϫ5 ). SNPs with a qϽ0.25 across phenotypes not previously reported in the Framingham Study (SNPs in the CRP, CCL2, and SELP genes) are tabulated ( Table 2 ). The top cis-acting associations for SNPs not previously reported by our group (SELP SNPs-P-selectin concentrations were previously reported 20 ) were observed in the ICAM1 gene in relation to ICAM-1 concentrations (rs1799969, Arg/Gly missense, Pϭ1.32ϫ10 Ϫ8 ). Results for the top SNPs (qϽ0.25) presented in Table 2 were consistent with age-and sex-adjusted models (supplement Table X ).
Secondary Analyses
Interactions Accounting for multiple testing, there was no evidence for strong interactions between the SNPs most highly associated with each phenotype and sex, age, smoking status, and body mass index (supplement Table IV ). 
Replication From the Literature
We were able to replicate 2 previously reported ICAM1 SNPs in our database (supplement Table VI) ; rs1799969 was congruent with our top ICAM1 finding. SNPs in IL6, CD14, and NOS3 genes in relation to IL-6 concentrations were not replicated. We could confirm rs8192284 in the IL6R gene in relation to IL-6 concentrations, as well as three SNPs in the CCL2 gene in association with monocyte attractant protein-1.
External Replication
In the AtheroGene cohort, predominantly consisting of coronary artery disease patients (nϭ895 to 1752), only rs3732764 in the P2RY12 gene, reached borderline significance, Pϭ0.05. None of the other top findings could be replicated (supplement Table VII ).
Discussion
Principal Findings
We report heritability and genetic associations for a broad panel of carefully selected inflammatory biomarkers and SNPs in a moderately-sized community-based sample. We observed significant heritability for 11 inflammatory biomarker traits, with heritability estimates ranging from 10.9% to 44.8%, including estimates for isoprostanes, myeloperoxidase, and tumor necrosis factor receptor II that have not been published before. We detected substantial environmental correlations between many systemic biomarkers and some pair-wise genetic correlations between biomarker traits. Top findings of the broad candidate gene approach, comprising 1943 SNPs, confirmed recent results from the literature for cis-acting SNPs in ICAM1 and CRP genes and trans-acting IL6R association with IL-6 concentrations. In addition, novel associations we report were significant cis-acting MPO SNPs with myeloperoxidase concentrations, and trans-acting APCS SNPs in relation to monocyte chemoattractant protein-1. We were not able to replicate our results in a cohort of patients with prevalent coronary artery disease. We present age-and sex-adjusted, as well as multivariable-adjusted phenotype-genotype associations online, so that investigators can download the data and conduct their own analyses. Furthermore, to place our results into perspective, we include comprehensive reviews of the inflammatory biomarker heritability and candidate gene literature in the supplement.
Environmental and Genetic Correlations
The examination of bivariate biomarker trait correlations, partitioned into shared genetic and environmental components, 28 clearly revealed that environmental factors contributed a larger extent to observed correlations of circulating biomarker concentrations compared with additive 
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Response variables were multivariable-adjusted biomarker residuals (see methods). Comparison was made using the homozygotes of the major allele as the reference group. Partial R 2 is the proportion of residual variance explained by the SNP. *Chr stands for chromosome. The replication p value for AtheroGene cohort is provided for genotyped SNPs (details Supplement Table 7 ). Reported P-value for rs1799969 ranged from Յ0.05 toϽ0.0001; 24, 27 for rs8192284 from 2*10 Ϫ8 from to 2.0*10 Ϫ9,26,27 R 2 linkage disequilibrium of nearby SNPs is provided in Supplement Table 8 . Means and standard deviation by genotype are provided in Supplement Table 9 .
Betas are the regression coefficients.
genetic effects. The strength of the genetic and environmental correlations we observed was lower than reported in recent twin studies. 29 Only CRP in relation to fibrinogen, and ICAM1 and IL-6 showed moderate genetic, as well as environmental correlations. Compared with the previous literature, we provide correlations for a large inflammatory marker panel.
Heritability
Heritability for inflammatory biomarkers has been reported by Framingham and other researchers for extensively investigated traits like CRP, IL-6, ICAM1, and monocyte chemoattractant protein-1 (supplement Table  V) . 10 -12,30,31 The present cohort convincingly demonstrated a modest to moderate proportion of variability explained by descent in a large panel of distinct inflammatory biomarkers, even biomarkers with known higher intraindividual variability and measurement coefficients of variation like isoprostanes. 32
Genetic Association
As coding genes have the highest likelihood of association with encoded proteins most biomarker candidate gene association analyses have been performed for cis-acting genes. Not surprisingly, our strongest association finding was in the SELP gene in relation to P-selectin concentrations, which has previously been reported in Framingham 20 and independent studies. 33, 34 For several tagging SNPs, we and others were able to show moderate associations between common genetic variation in the respective coding genes for CRP 14, 21, 35 and ICAM1 24,36 concentrations after accounting for known covariates (for additional replication please see supplement Table VI ). We further hypothesized that inflammatory genes are related to circulating biomarkers not coded for by the gene (trans-acting genes). We extended current knowledge by examining a broad panel of 233 inflammatory candidate genes. The aim was to capture trans-acting genotypes that might contribute at the genetic level to the known strong interrelations of inflammatory pathways at the biomarker level. We confirmed the strong association of SNP rs8192284 in IL6R with IL-6 phenotype. 26 The observed relation has a functional explanation because the amino acid exchange leads to an alteration at the receptor cleavage site, which increases soluble IL-6 receptor concentrations and thus affects circulating IL-6. 26, 37 The independent evidence in ethnically different groups and a plausible pathophysiological explanation have turned this SNP into a very promising candidate polymorphism.
Less evidence is available that would help to explain the top finding of 2 SNPs in the APCS gene in relation to serum monocyte chemoattractant protein-1 concentrations. The APCS SNPs, all located in the 5Ј gene region without relevant linkage disequilibrium to SNPs with known function, belong to a gene with multiple polyadenylation sites encoding a highly conserved glycoprotein of the pentraxin family, serum amyloid P component. 38 Serum amyloid component shares considerable sequence homology with CRP resulting from gene duplication during evolution. Serum amyloid P opsonizes apoptotic cells, an important step in their clearance. 39 Amyloid P is found in atherosclerotic plaques 40 and circulating concentrations have been related to clinical cardiovascular disease in an elderly, multiethnic communitybased cohort. 41 Genetic data in humans are scant. We reported a linkage peak for monocyte attractant protein-1 on chromosome 1, which extends over the APCS gene locus and provides additional evidence for a potential association. 10 Ongoing genome-wide association studies will help to identify the true variants. None of the polymorphisms in the CCL2 gene reported in the FHS cohort reached experiment-wide significance, but showed nominally significant associations with the same directionality. 42 Myeloperoxidase, has been recognized for its role in noninfectious inflammatory diseases, and as an important modulator of vasomotor function in vascular inflammation. 43 Two non-HapMap SNPs have been described in association with myeloperoxidase activity (rs28365049 and rs34097845). The functional promotor polymorphism (Ϫ463G/A) containing an Alu element is related to myeloperoxidase expression. 44 It has been linked to inflammatory diseases like Alzheimer's disease, 45 and atherosclerotic disease. 46 In the current cohort, we provide evidence on the significance of a new SNP, rs28730837, a Val/Ala missense variation, with regard to myeloperoxidase concentration.
Replication From the Literature
Compared with the large number of published studies, only few met our inclusion criteria of sample size Ն500 participants for an in-silico replication attempt. We were able to replicate mostly cis-acting SNPs from the literature for ICAM1 and CCL2 genes and one prominent transacting association of the recently reported SNP rs8192284 in IL6R gene in relation to IL-6. Associations for SNPs in CD14 and NOS3 genes with IL-6, previously seen in patients with coronary artery disease could not be confirmed and may indicate spurious or disease-specific findings. 47, 48 
Strengths and Limitations
The Framingham Study constitutes a single-center familybased community cohort with limited referral bias, stringent biomarker quality control, well-documented, and routinely ascertained environmental confounders, which facilitate multivariable models and heritability analyses. The choice of multiple biomarkers from scientifically sound candidate pathways based on basic and human studies further increases the current study's comprehensiveness. The broad range of SNPs chosen for association reduces bias observed in candidate gene approaches and may uncover both cis and trans regulators. 49 Although our study underscores the problems of multiple testing, in contrast to many recent publications, a q-value method was applied with conservative thresholds, to minimize falsepositive findings without instituting overly strict Bonferroni corrections. In addition, we provide a downloadable excel file at our website of all inflammatory marker-SNP associations tested that will facilitate replication by external investigators (data file included as reviewers' electronic supplement will be posted on publication). Furthermore, we provide a comprehensive review of most previous publications examining heritability and the associations between SNPs and circulating inflammatory biomarkers.
Some limitations meriting consideration are that the significant results are currently restricted to one study group. We were unable to replicate our findings in an independent cohort with coronary artery disease. Nonreplication may be due to a relatively low number of genotyped individuals and their preexisting coronary disease, which is known to elevate biomarker concentrations. As noted by Chanock et al, 50 phenotype and participant heterogeneity will compromise the likelihood of replication. The selected nature of AtheroGene, is corroborated by the observation, that the repeatedly validated association of IL6R rs8192284 26 was replicated in the FHS cohort but not in the AtheroGene cohort. We used an older HapMap build (build 35), and thus may have missed important variants.
Intermediate cardiovascular phenotypes (ie, hypertension) are strongly correlated with inflammatory activity; multivariable-adjustment may limit our ability to detect pleiotropic environmental and genetic effects related to inflammation. To reduce the high multiple testing burden, we specified à priori that our primary analyses would be multivariable-adjusted models.
Generalizability of the results is limited by the ethnically homogenous cohort; biomarker concentrations vary by ethnicity. 51 For other ethnicities, a slightly different set of informative SNPs would have been chosen. 52 On the other hand, the potential for population stratification was reduced by racial homogeneity. 53 We acknowledge that our cohort had only moderate power to detect modest effects; a potential for false-negative findings is evident. Inherent to single-cohort genetic association studies, our results should be viewed as hypothesis generating; replication in independent samples is necessary. 
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